Hagar Sachs

Hagar Sachs is an accomplished professional with extensive experience in regulatory affairs and quality assurance within the pharmaceutical and medical device sectors. Currently serving as the Head of Regulatory Affairs and Quality Assurance at Nucleai since June 2022, Hagar previously held key positions such as Director of QA/RA at DarioHealth Corp. and Director of Quality and Clinical Affairs at MaxQ AI. Hagar's expertise includes the establishment and implementation of Quality Management Systems (QMS), risk-based design of QMS processes, and regulatory submissions for clinical studies. Prior roles also include consulting in QMS establishment at Dot Compliance, project management at DOT Business Consulting Services, and leadership in regulatory affairs at Tiltan Pharma Ltd. Hagar holds an M.Sc. in Developmental Biology and Cancer Research from The Hebrew University Hadassah Medical School and a B.Pharm. from The Hebrew University's School of Pharmacy.